Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Retrospective analysis of glycan-related biomarkers based on clinical laboratory data in two medical centers during the past 6 years.

Zhang M, Dou H, Yang D, Shan M, Li X, Hao C, Zhang Y, Zeng P, He Y, Liu Y, Fu J, Wang W, Hu M, Li H, Tian Q, Lei S, Zhang L.

Prog Mol Biol Transl Sci. 2019;162:141-163. doi: 10.1016/bs.pmbts.2019.01.003. Epub 2019 Mar 6.

PMID:
30905446
2.

Serum CA199 levels are significantly increased in patients suffering from liver, lung, and other diseases.

Zeng P, Li H, Chen Y, Pei H, Zhang L.

Prog Mol Biol Transl Sci. 2019;162:253-264. doi: 10.1016/bs.pmbts.2018.12.010. Epub 2019 Mar 8.

PMID:
30905455
3.

The sensitivity and specificity of serum glycan-based biomarkers for cancer detection.

Tang Y, Cui Y, Zhang S, Zhang L.

Prog Mol Biol Transl Sci. 2019;162:121-140. doi: 10.1016/bs.pmbts.2019.01.010. Epub 2019 Mar 6.

PMID:
30905445
4.

Serum CA153 as biomarker for cancer and noncancer diseases.

Li X, Xu Y, Zhang L.

Prog Mol Biol Transl Sci. 2019;162:265-276. doi: 10.1016/bs.pmbts.2019.01.005. Epub 2019 Mar 6.

PMID:
30905456
5.

Correlation between serum CA724 and gastric cancer: multiple analyses based on Chinese population.

Chen XZ, Zhang WK, Yang K, Wang LL, Liu J, Wang L, Hu JK, Zhang B, Chen ZX, Chen JP, Zhou ZG, Mo XM.

Mol Biol Rep. 2012 Sep;39(9):9031-9. doi: 10.1007/s11033-012-1774-x. Epub 2012 Jun 30.

PMID:
22752725
6.

Increased serum CA724 levels in patients suffering gout vs cancers.

Zhang Y, Zhang M, Bai X, Li C, Zhang L.

Prog Mol Biol Transl Sci. 2019;162:177-186. doi: 10.1016/bs.pmbts.2018.12.005. Epub 2019 Feb 20.

PMID:
30905448
7.

Serum AFP levels in patients suffering from 47 different types of cancers and noncancer diseases.

He Y, Lu H, Zhang L.

Prog Mol Biol Transl Sci. 2019;162:199-212. doi: 10.1016/bs.pmbts.2019.01.001. Epub 2019 Mar 6.

PMID:
30905450
8.

Serum CEA levels in 49 different types of cancer and noncancer diseases.

Hao C, Zhang G, Zhang L.

Prog Mol Biol Transl Sci. 2019;162:213-227. doi: 10.1016/bs.pmbts.2018.12.011. Epub 2019 Mar 6.

PMID:
30905451
9.

Serum CA125 levels are decreased in rectal cancer but increased in fibrosis-associated diseases and in most types of cancers.

Zhang M, Zhang Y, Fu J, Zhang L.

Prog Mol Biol Transl Sci. 2019;162:241-252. doi: 10.1016/bs.pmbts.2018.12.012. Epub 2019 Mar 6.

PMID:
30905453
10.

Serum SCCA levels in patients suffering cancers or other diseases.

Yang D, Wang J, Zhang L.

Prog Mol Biol Transl Sci. 2019;162:165-175. doi: 10.1016/bs.pmbts.2018.12.004. Epub 2019 Mar 9.

PMID:
30905447
11.

Serum CA50 levels in patients with cancers and other diseases.

Shan M, Tian Q, Zhang L.

Prog Mol Biol Transl Sci. 2019;162:187-198. doi: 10.1016/bs.pmbts.2018.12.006. Epub 2019 Mar 9.

PMID:
30905449
12.

CA242 as a biomarker for pancreatic cancer and other diseases.

Dou H, Sun G, Zhang L.

Prog Mol Biol Transl Sci. 2019;162:229-239. doi: 10.1016/bs.pmbts.2018.12.007. Epub 2019 Mar 6.

PMID:
30905452
13.

Quantitative comparisons of summary receiver operating characteristics (sROC) curves among conventional serological tumor biomarkers for predicting gastric cancer in Chinese population.

Chen XZ, Zhang WH, Yang K, Zhang B, Chen ZX, Chen JP, Zhou ZG, Hu JK.

Tumour Biol. 2014 Sep;35(9):9015-22. doi: 10.1007/s13277-014-1986-x. Epub 2014 Jun 7.

PMID:
24906604
14.

Serum CA242, CA199, CA125, CEA, and TSGF are Biomarkers for the Efficacy and Prognosis of Cryoablation in Pancreatic Cancer Patients.

Chen Y, Gao SG, Chen JM, Wang GP, Wang ZF, Zhou B, Jin CH, Yang YT, Feng XS.

Cell Biochem Biophys. 2015 Apr;71(3):1287-91. doi: 10.1007/s12013-014-0345-2.

PMID:
25486903
15.

CEA, AFP, CA125, CA153 and CA199 in malignant pleural effusions predict the cause.

Wang XF, Wu YH, Wang MS, Wang YS.

Asian Pac J Cancer Prev. 2014;15(1):363-8.

16.

[Diagnostic value of determination of CEA, CA125, CA153 and CA199 assay in pleural fluid for lung cancer].

Wu G, Ba J, Wang E, Teng Y, Fan X.

Zhongguo Fei Ai Za Zhi. 2004 Feb 20;7(1):35-7. doi: 10.3779/j.issn.1009-3419.2004.01.09. Chinese.

17.

[A preliminary study of retinoblastoma-related serum tumor markers].

Liu ZP, Zhou KY, Chen LL, Xiao ZH, Chen YZ.

Zhongguo Dang Dai Er Ke Za Zhi. 2017 Mar;19(3):318-321. Chinese.

18.

Levels of CEA, CA153, CA199, CA724 and AFP in nipple discharge of breast cancer patients.

Zhao S, Mei Y, Wang Y, Zhu J, Zheng G, Ma R.

Int J Clin Exp Med. 2015 Nov 15;8(11):20837-44. eCollection 2015.

19.

Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer.

Wang YF, Feng FL, Zhao XH, Ye ZX, Zeng HP, Li Z, Jiang XQ, Peng ZH.

World J Gastroenterol. 2014 Apr 14;20(14):4085-92. doi: 10.3748/wjg.v20.i14.4085. Review.

20.

[Cancer clearance for "unprovoked" venous thromboembolism cases].

Ye W, Chen Y, Li M, Jiang C, Li D, Liu C.

Zhonghua Yi Xue Za Zhi. 2014 Apr 22;94(15):1143-6. Chinese.

PMID:
24924711

Supplemental Content

Support Center